Bragging About My Own Book

Big Cannabis took a step back this week as investors ponder the ultimate future of the largest cultivators. In a world where Aurora Cannabis Inc. (NYSE:ACB) needs to sell $125 million in stock to survive, size is clearly not the key to success.

But on my end of the industry, we’re having a lot of fun. Two of the stocks in my IPO Edge portfolio are still ringing triple-digit-percentage bells.

While I normally keep those stocks secret to reserve the best opportunities for subscribers, I’m going to brag a little today. The elite have already gotten a taste. Now it’s your turn to take a look.

Juva Life Inc. (OTC:JUVAF) is tiny, not even a fraction of the size of ACB or the other giants. We were here at $0.75. You can do that math yourself.

The allure is that unlike the giants, JUVAF has a blue-sky future ahead of it. The business model goes a lot deeper than simply growing a lot of plant product.

Management has learned from the giants’ mistakes. They aren’t trying to become a $10 billion unicorn on their own. But if they get an acquisition offer for $2 billion down the road, shareholders will cheer.

And while HempFusion Wellness Inc. (TSX:CBD.U) is only available in Canada, those who caught the opening-day shares a few weeks ago are already applauding. This isn’t cannabis. It isn’t even growing hemp.

We’re here for value-added consumer products enhanced with hemp derivatives. That’s the true “Cannabis 2.0” story Wall Street was promised years ago.

If you’re tired of generic cultivators, go small. And when I think of great things in small packages, IPO Edge is the place.